The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Millennium Pharmaceuticals, Inc.

Millennium Pharmaceuticals, Inc.
Nasdaq: MLNM
Change
symbol:
     
 NEWS FROM THE WIRES
Funds: Fund investors eye biotech
Aug 16 2001 09:33 AM PDT

Funds: Fund investors eye biotech
Aug 16 2001 09:33 AM PDT

Tokyo's Nikkei hits 16-year low, Advantest weighs
Aug 13 2001 12:37 AM PDT

Aventis, Millennium expand inflammatory disease JV
Aug 13 2001 12:36 AM PDT

Applera to spend $75 million to develop own drugs
Jul 24 2001 05:33 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
Biotech: Desperate No More
Jun 27 2001 07:21 AM PDT

Celera Catches the Drug Bug
Jun 13 2001 04:27 PM PDT

 PROFILE
Millennium Pharmaceuticals looks for the genetic basis of a disease to stop it at its roots. It develops treatments and diagnostics primarily for three disease targets: cancer, metabolic diseases, and inflammation. Millennium derives its revenue from research and development alliances with such companies as Bayer (27%; it owns about 10% of Millennium), Monsanto (22%), and American Home Products. With ILEX Oncology, the firm's LeukoSite subsidiary has developed CAMPATH, a potential leukemia treatment that has received FDA fast-track status. Other collaborations include Abbott Laboratories (for metabolic diseases), Eli Lilly (cancer and cardiovascular disease), and Becton Dickinson (cancer diagnostics).

 COMPETITION
Amgen Inc. (AMGN)
Chiron Corporation (CHIR)
Genentech, Inc. (DNA)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 196.30
1-Yr. Sales Growth: 6.9%
Employees: 1,330
Revenue per employee: $147,593.98

 KEY PEOPLE
• Mark J. Levin
    CEO
• Kevin P. Starr
    CFO

 CONTACT INFO
75 Sidney St.
Cambridge, MA 02139
US
Phone: 617-679-7000
Fax: 617-374-9379
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001